Nano-Sized Drug Carriers Could Be The Future For Patients With Lung Disease, Imperial College London Study Reveals

Metallic nanomolecules capable of carrying drugs to exactly where they are needed could one day help to treat patients with a fatal lung condition.

Scientists based at Imperial College London have tested a new type of nanoparticle called metal organic frameworks (MOF) – tiny metal cages less than 100 nanometres across that can be loaded with drug molecules – which they believe could potentially be used to treat patients with a devastating condition called pulmonary arterial hypertension (PAH).

In PAH the blood vessels of the lungs constrict and thicken, increasing blood pressure and causing the right side of the heart to work harder and harder, until it eventually fails.

Back to news